Group Sequential Methods for the Win Ratio
Tracy Bergemann, Tim Hanson

TL;DR
This paper develops a framework for applying classical group sequential methods to win ratio endpoints in clinical trials, ensuring proper control of Type I error and enabling early stopping.
Contribution
It derives the covariance structure of U-statistics for the win ratio, proving that incremental test statistics are asymptotically independent, facilitating standard group sequential approaches.
Findings
Covariance structure confirms independence of incremental statistics.
Alpha-spending methods effectively control Type I error.
Application to clinical trial data demonstrates early stopping potential.
Abstract
The win ratio is increasingly used in randomized trials due to its intuitive clinical interpretation, ability to incorporate the relative importance of composite endpoints, and its capacity for combining different types of outcomes (e.g. time-to-event, binary, counts, etc.) to be combined. There are open questions, however, about how to implement adaptive design approaches when the primary endpoint is a win ratio, including in group sequential designs. A key requirement allowing for straightforward application of classical group sequential methods is the independence of incremental interim test statistics. This paper derives the covariance structure of incremental U-statistics that evaluate the win ratio under its asymptotic distribution. The derived covariance shows that the independent increments assumption holds for the asymptotic distribution of U-statistics that test the win ratio.…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Statistical Methods and Bayesian Inference · Advanced Causal Inference Techniques
